zotepine has been researched along with Chronic Disease in 4 studies
zotepine: structure
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zotepine is an antipsychotic drug with proven efficacy for treatment of acute episodes of schizophrenia." | 9.09 | Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia. ( Butler, A; Cooper, SJ; Raniwalla, J; Tweed, J; Welch, C, 2000) |
| "Zotepine is a new tricyclic neuroleptic with a pharmacological profile comparable to substances like Thioridazine and Chlorpromazine." | 5.27 | Zotepine in the treatment of negative symptoms in chronic schizophrenia. ( Barnas, C; Fleischhacker, WW; Hinterhuber, H; Stuppäck, C; Unterweger, B, 1987) |
| "Zotepine is an antipsychotic drug with proven efficacy for treatment of acute episodes of schizophrenia." | 5.09 | Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia. ( Butler, A; Cooper, SJ; Raniwalla, J; Tweed, J; Welch, C, 2000) |
| "Zotepine is a new tricyclic neuroleptic with a pharmacological profile comparable to substances like Thioridazine and Chlorpromazine." | 1.27 | Zotepine in the treatment of negative symptoms in chronic schizophrenia. ( Barnas, C; Fleischhacker, WW; Hinterhuber, H; Stuppäck, C; Unterweger, B, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, SJ | 1 |
| Butler, A | 1 |
| Tweed, J | 1 |
| Welch, C | 1 |
| Raniwalla, J | 1 |
| Barnas, C | 3 |
| Stuppäck, CH | 2 |
| Miller, C | 2 |
| Haring, C | 2 |
| Sperner-Unterweger, B | 2 |
| Fleischhacker, WW | 3 |
| Stuppäck, C | 1 |
| Unterweger, B | 1 |
| Hinterhuber, H | 1 |
3 trials available for zotepine and Chronic Disease
| Article | Year |
|---|---|
Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chronic Disease; Dibenzothiepins; Double-Blind Method | 2000 |
Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dibenzothiepins; Double-Blind Method; Female; Haloperi | 1992 |
[Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dibenzothiepins; Double-Blind Method; Dyskinesia, Drug | 1991 |
1 other study available for zotepine and Chronic Disease
| Article | Year |
|---|---|
Zotepine in the treatment of negative symptoms in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dibenzothiepins; Female; Humans; Male; Psychiatric Sta | 1987 |